24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
FSD Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:21
Former Mossad chief and real estate tycoons back controversial Israeli drone company
13:31
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
08:51
Jensen Huang: Nvidia “100% in Israel” despite war
21:56
Israel’s war with Iran costs up to $550 million a day
More stories
Buzz
Most popular
Daily
Weekly
1
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
2
Former Mossad chief and real estate tycoons back controversial Israeli drone company
3
Israel’s war with Iran costs up to $550 million a day
4
Israel orders airborne laser system for fighter jets and helicopters
5
Jensen Huang: Nvidia “100% in Israel” despite war
More news
FSD Pharma
3 stories about FSD Pharma
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock
23.10.18
|
Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
